Table 3 Estimated prevalence of the recorded diseases
| Â | N | Estimated prevalence (per 10,000 residents) | 95% CI |
|---|---|---|---|
A. General | 1099 | 552.0 | (471.0 - 633.0) |
B. Blood, lymphatics | 486 | 240.6 | (175.0 - 306.2) |
C. Digestive | 1688 | 844.6 | (673.2 - 1016.1) |
F. Eye | 451 | 222.8 | (167.1 - 278.6) |
H. Ear | 207 | 104.8 | (45.5 - 164.1) |
K. Circulatory | 7026 | 3409.2 | (2959.4 - 3860.3) |
   Elevated blood pressure | 3719 | 1813.2 | (1505.2 - 2121.1) |
   Coronary heart disease | 2321 | 1107.2 | (710.2 - 1504.2) |
L. Musculoskeletal | 3150 | 1551.4 | (1448.1 - 1654.7) |
   Osteoarthritis | 684 | 340.0 | (249.6 - 430.4) |
   Osteoporosis | 1047 | 500.7 | (403.3 - 598.0) |
N. Neurological | 975 | 489.0 | (420.4 - 557.6) |
P. Psychological | 1968 | 949.9 | (669.8 - 1230.0) |
   Depression | 580 | 269.1 | (79.9 - 458.2) |
   Anxiety disorders | 376 | 191.4 | (132.4 - 250.4) |
R. Respiratory | 3122 | 1548.3 | (1353.7 - 1742.9) |
   Asthma | 103 | 53.8 | (34.2 - 73.4) |
   COPD | 706 | 349.6 | (277.7 - 421.6) |
S. Skin | 927 | 452.7 | (381.9 - 523.6) |
T. Endocrine, metabolic and nutritional | 4058 | 1945.1 | (1641.7 - 2248.5) |
   Lipid disorder | 2026 | 960.4 | (741.4 - 1179.4) |
   Diabetes | 1472 | 714.6 | (646.9 - 782.4) |
U. Urology | 545 | 268.8 | (193.6 - 344.0) |
X. Genital Female | 242 | 120.7 | (99.4 - 142.1) |
Y. Genital male | 302 | 147.5 | (114.7 - 180.3) |